InvestorsHub Logo
Followers 1
Posts 207
Boards Moderated 0
Alias Born 08/30/2018

Re: None

Wednesday, 09/05/2018 10:28:39 AM

Wednesday, September 05, 2018 10:28:39 AM

Post# of 2470
Article: What Canopy and Constellation need is Sproutly...

(I didn't write this.. I saw this post in stockhouse.com srutf board, wanted to share it here. Great news/future for Sproutly)

Article: What Canopy and Constellation need is Sproutly...
Here’s what Canopy and Constellation need to acquire for their plans to reach full effect:

Beverage tech: If Constellation has an eye on the potential for a weed/liquor crossover, they need to get the tech right, and that’s not easy
Top pick: SPROUTLY (SPR.C)

Sproutly just closed their acquisition of Infusion Biosciences and, frankly, if what IB says they do is accurate, we can put down the glasses and call the other runners off the track.


Extraction is costly and requires a significant capex and opex investment. Infusion’s technique has the potential to radically change how we go from weed grown to weed utilized in consumer products.

There are companies that are working on making cannabis oils water soluble (EG: turn them into powder), but the process tends to break down a lot of what’s good about those oils as it goes. Essentially ‘washing’ the good stuff off the plant into a water product is the golden fleece of this business, and Sproutly thinks they have it.

....

They’re working on proving out exactly how well it works now.

[Trace Research Institute founder Gordon] Fagras commented: “This is why our research collaboration with Infusion Biosciences is so unique in that the samples are naturally in water solution(s) where, we have seen not seen fallout of any manner so far, and thus we feel they are highly shelf stable. Modifying sample processing and analytical testing with these concentrated water solutions of cannabinoids (and terpenes) should provide us with a unique opportunity to develop analytical methods for cannabis beverages.”

Sproutly has a licensed LP facility as well as the Infusion Biosciences tech, so their current $83m market cap is an absolute steal, in my opinion, and make them a target not just for Canopy/Constellation, but for any company looking to not just make a decorative weed investment, but a first step into actual products.

Full atricle here...

https://equity.guru/2018/09/04/canopy-growth-corp-weed-t-5-billion-buy-something-whats-list/


Read more at http://www.stockhouse.com/companies/bullboard?symbol=srutf&postid=28563136#m84SYVsQgbVF6dM4.99